Business Equipment & Supplies
Compare Stocks
5 / 10Stock Comparison
ACCL vs ACCO vs AVY vs SPB vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Business Equipment & Supplies
Business Equipment & Supplies
Household & Personal Products
Medical - Care Facilities
ACCL vs ACCO vs AVY vs SPB vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Business Equipment & Supplies | Business Equipment & Supplies | Business Equipment & Supplies | Household & Personal Products | Medical - Care Facilities |
| Market Cap | $20M | $362M | $12.32B | $1.87B | $10.28B |
| Revenue (TTM) | $559K | $1.55B | $9.01B | $2.82B | $5.27B |
| Net Income (TTM) | $127K | $74M | $690M | $126M | $363M |
| Gross Margin | 48.5% | 30.7% | 28.8% | 36.8% | 15.2% |
| Operating Margin | 24.2% | 7.9% | 12.4% | 5.3% | 8.5% |
| Forward P/E | 160.4x | 4.5x | 15.9x | 15.3x | 23.3x |
| Total Debt | $11K | $921M | $3.73B | $654M | $4.15B |
| Cash & Equiv. | $261K | $64M | $203M | $124M | $504M |
ACCL vs ACCO vs AVY vs SPB vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ACCO Brands Corpora… (ACCO) | 100 | 63.3 | -36.7% |
| Avery Dennison Corp… (AVY) | 100 | 144.7 | +44.7% |
| Spectrum Brands Hol… (SPB) | 100 | 170.4 | +70.4% |
| The Ensign Group, I… (ENSG) | 100 | 402.7 | +302.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACCL vs ACCO vs AVY vs SPB vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACCL has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.73, Low D/E 7.2%, current ratio 1.71x
- 22.7% margin vs SPB's 4.5%
- 31.5% ROA vs ACCO's 3.2%
ACCO is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (4.5x vs 23.3x)
- 7.3% yield, vs AVY's 2.3%
AVY is the clearest fit if your priority is income & stability.
- Dividend streak 15 yrs, beta 0.73, yield 2.3%
SPB is the clearest fit if your priority is valuation efficiency and defensive.
- PEG 1.18 vs AVY's 2.73
- Beta 0.87, yield 2.3%, current ratio 2.26x
- +24.9% vs ACCL's -64.0%
ENSG ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 8.2% 10Y total return vs AVY's 144.3%
- 18.7% revenue growth vs ACCO's -8.5%
- Beta 0.38 vs ACCO's 1.35
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs ACCO's -8.5% | |
| Value | Lower P/E (4.5x vs 23.3x) | |
| Quality / Margins | 22.7% margin vs SPB's 4.5% | |
| Stability / Safety | Beta 0.38 vs ACCO's 1.35 | |
| Dividends | 7.3% yield, vs AVY's 2.3% | |
| Momentum (1Y) | +24.9% vs ACCL's -64.0% | |
| Efficiency (ROA) | 31.5% ROA vs ACCO's 3.2% |
ACCL vs ACCO vs AVY vs SPB vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ACCL vs ACCO vs AVY vs SPB vs ENSG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACCL leads in 2 of 6 categories
ACCO leads 1 • ENSG leads 1 • AVY leads 0 • SPB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ACCL leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVY is the larger business by revenue, generating $9.0B annually — 16119.3x ACCL's $558,690. ACCL is the more profitable business, keeping 22.7% of every revenue dollar as net income compared to SPB's 4.5%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $558,690 | $1.6B | $9.0B | $2.8B | $5.3B |
| EBITDAEarnings before interest/tax | — | $177M | $1.3B | $249M | $558M |
| Net IncomeAfter-tax profit | — | $74M | $690M | $126M | $363M |
| Free Cash FlowCash after capex | — | $49M | $873M | $290M | $406M |
| Gross MarginGross profit ÷ Revenue | +48.5% | +30.7% | +28.8% | +36.8% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +24.2% | +7.9% | +12.4% | +5.3% | +8.5% |
| Net MarginNet income ÷ Revenue | +22.7% | +4.8% | +7.7% | +4.5% | +6.9% |
| FCF MarginFCF ÷ Revenue | +25.7% | +3.2% | +9.7% | +10.3% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.3% | +7.0% | +4.9% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +2.4% | +4.3% | +27.2% | +21.9% |
Valuation Metrics
ACCO leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 8.9x trailing earnings, ACCO trades at a 94% valuation discount to ACCL's 160.4x P/E. Adjusting for growth (PEG ratio), SPB offers better value at 1.61x vs AVY's 3.12x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $20M | $362M | $12.3B | $1.9B | $10.3B |
| Enterprise ValueMkt cap + debt − cash | $20M | $1.2B | $15.8B | $2.4B | $13.9B |
| Trailing P/EPrice ÷ TTM EPS | 160.44x | 8.91x | 18.24x | 20.89x | 30.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 4.51x | 15.93x | 15.32x | 23.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.12x | 1.61x | 2.18x |
| EV / EBITDAEnterprise value multiple | 135.40x | 6.73x | 11.77x | 10.77x | 25.89x |
| Price / SalesMarket cap ÷ Revenue | 36.45x | 0.24x | 1.39x | 0.67x | 2.03x |
| Price / BookPrice ÷ Book value/share | 137.96x | 0.55x | 5.53x | 1.09x | 4.64x |
| Price / FCFMarket cap ÷ FCF | 141.78x | 7.12x | 17.29x | 11.28x | 27.74x |
Profitability & Efficiency
ACCL leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ACCL delivers a 61.0% return on equity — every $100 of shareholder capital generates $61 in annual profit, vs $7 for SPB. ACCL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), ACCL scores 8/9 vs ENSG's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +61.0% | +11.3% | +30.8% | +6.6% | +16.6% |
| ROA (TTM)Return on assets | +31.5% | +3.2% | +7.8% | +3.7% | +6.8% |
| ROICReturn on invested capital | — | +5.5% | +15.2% | +3.9% | +7.0% |
| ROCEReturn on capital employed | +63.8% | +6.1% | +18.9% | +4.2% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.07x | 1.39x | 1.66x | 0.34x | 1.86x |
| Net DebtTotal debt minus cash | -$250,501 | $856M | $3.5B | $531M | $3.7B |
| Cash & Equiv.Liquid assets | $261,091 | $64M | $203M | $124M | $504M |
| Total DebtShort + long-term debt | $10,590 | $921M | $3.7B | $654M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 2.50x | 7.70x | 4.63x | 88.33x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $21,678 today (with dividends reinvested), compared to $3,605 for ACCL. Over the past 12 months, SPB leads with a +24.9% total return vs ACCL's -64.0%. The 3-year compound annual growth rate (CAGR) favors ENSG at 24.4% vs ACCL's -28.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -47.1% | +8.3% | -11.7% | +35.1% | +1.3% |
| 1-Year ReturnPast 12 months | -64.0% | +8.8% | -10.6% | +24.9% | +24.5% |
| 3-Year ReturnCumulative with dividends | -64.0% | -7.5% | -1.5% | +21.6% | +92.4% |
| 5-Year ReturnCumulative with dividends | -64.0% | -41.4% | -18.0% | -0.8% | +116.8% |
| 10-Year ReturnCumulative with dividends | -64.0% | -37.0% | +144.3% | +12.6% | +815.2% |
| CAGR (3Y)Annualised 3-year return | -28.8% | -2.6% | -0.5% | +6.7% | +24.4% |
Risk & Volatility
Evenly matched — SPB and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than ACCO's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPB currently trades 92.7% from its 52-week high vs ACCL's 29.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.73x | 1.35x | 0.73x | 0.87x | 0.38x |
| 52-Week HighHighest price in past year | $5.00 | $4.29 | $199.54 | $86.95 | $218.00 |
| 52-Week LowLowest price in past year | $1.23 | $2.81 | $156.23 | $49.99 | $134.79 |
| % of 52W HighCurrent price vs 52-week peak | +29.2% | +91.4% | +80.2% | +92.7% | +80.8% |
| RSI (14)Momentum oscillator 0–100 | 48.7 | 66.5 | 40.9 | 47.0 | 18.7 |
| Avg Volume (50D)Average daily shares traded | 46K | 1.2M | 601K | 322K | 376K |
Analyst Outlook
Evenly matched — ACCO and AVY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACCO as "Hold", AVY as "Buy", SPB as "Buy", ENSG as "Buy". Consensus price targets imply 104.1% upside for ACCO (target: $8) vs 8.8% for SPB (target: $88). For income investors, ACCO offers the higher dividend yield at 7.33% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $8.00 | $214.75 | $87.75 | $222.33 |
| # AnalystsCovering analysts | — | 7 | 18 | 21 | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.0% | +7.3% | +2.3% | +2.3% | +0.1% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 | 1 | 12 |
| Dividend / ShareAnnual DPS | $0.00 | $0.29 | $3.73 | $1.86 | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.2% | +4.6% | +17.5% | +0.2% |
ACCL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACCO leads in 1 (Valuation Metrics). 2 tied.
ACCL vs ACCO vs AVY vs SPB vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACCL or ACCO or AVY or SPB or ENSG a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 8. 9x trailing P/E (4. 5x forward), making it the more compelling value choice. Analysts rate Avery Dennison Corporation (AVY) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACCL or ACCO or AVY or SPB or ENSG?
On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 8.
9x versus Acco Group Holdings Limited Ordinary Shares at 160. 4x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Spectrum Brands Holdings, Inc. wins at 1. 18x versus Avery Dennison Corporation's 2. 73x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — ACCL or ACCO or AVY or SPB or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +116. 8%, compared to -64. 0% for Acco Group Holdings Limited Ordinary Shares (ACCL). Over 10 years, the gap is even starker: ENSG returned +815. 2% versus ACCL's -64. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACCL or ACCO or AVY or SPB or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 38β versus ACCO Brands Corporation's 1. 35β — meaning ACCO is approximately 256% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Acco Group Holdings Limited Ordinary Shares (ACCL) carries a lower debt/equity ratio of 7% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACCL or ACCO or AVY or SPB or ENSG?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACCL or ACCO or AVY or SPB or ENSG?
Acco Group Holdings Limited Ordinary Shares (ACCL) is the more profitable company, earning 22.
7% net margin versus 2. 7% for ACCO Brands Corporation — meaning it keeps 22. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACCL leads at 24. 2% versus 4. 4% for SPB. At the gross margin level — before operating expenses — ACCL leads at 48. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACCL or ACCO or AVY or SPB or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Spectrum Brands Holdings, Inc. (SPB) is the more undervalued stock at a PEG of 1. 18x versus Avery Dennison Corporation's 2. 73x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4. 5x forward P/E versus 23. 3x for The Ensign Group, Inc. — 18. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 104. 1% to $8. 00.
08Which pays a better dividend — ACCL or ACCO or AVY or SPB or ENSG?
In this comparison, ACCO (7.
3% yield), AVY (2. 3% yield), SPB (2. 3% yield), ENSG (0. 1% yield) pay a dividend. ACCL does not pay a meaningful dividend and should not be held primarily for income.
09Is ACCL or ACCO or AVY or SPB or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), +815. 2% 10Y return). Both have compounded well over 10 years (ENSG: +815. 2%, ACCO: -37. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACCL and ACCO and AVY and SPB and ENSG?
These companies operate in different sectors (ACCL (Industrials) and ACCO (Industrials) and AVY (Industrials) and SPB (Consumer Defensive) and ENSG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ACCL is a small-cap high-growth stock; ACCO is a small-cap deep-value stock; AVY is a mid-cap quality compounder stock; SPB is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. ACCO, AVY, SPB pay a dividend while ACCL, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.